Freedom Broker Initiates Coverage on Arcturus Therapeutics Holdings Inc. (ARCT) with Buy

Market Context

Arcturus Therapeutics Holdings Inc. operates in the Healthcare sector. The stock currently trades at $7.66 with a market capitalization of $233.8M. The stock has declined 50.1% over the past 52 weeks.

Analyst coverage from Freedom Broker provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Arcturus Therapeutics Holdings Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Arcturus Therapeutics Holdings Inc.

Among the 10 most recent ratings: 5 Buy, 5 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 02, 2026	Freedom Broker	Buy	N/A
Mar 18, 2026	B. Riley Securities	Buy	N/A
Mar 05, 2026	Citigroup	Buy	N/A
Mar 04, 2026	Piper Sandler	Overweight	N/A
Mar 04, 2026	Citigroup	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View ARCT Stock Page